Common variable immune deficiency in children--clinical characteristics varies depending on defect in peripheral B

Barbara Piątosa1, Małgorzata Pac, Katarzyna Siewiera

  • 1Histocompatibility Laboratory, Children's Memorial Health Institute, Al. Dzieci Polskich 20, 04-730, Warsaw, Poland. b.piatosa@czd.pl

Insights

Early identification of Common Variable Immune Deficiency (CVID) in children is crucial. Analyzing B-cell maturation profiles can predict complications and guide treatment for pediatric CVID patients.

Area of Science:

  • Immunology
  • Pediatric Hematology/Oncology

Background:

  • Common Variable Immune Deficiency (CVID) is a heterogeneous disorder characterized by impaired antibody production, typically diagnosed in adulthood.
  • A subset of children also develops CVID, and early identification of those with a poorer prognosis is vital to prevent severe complications.

Purpose of the Study:

  • To correlate the clinical characteristics of pediatric patients with early-onset CVID with their peripheral B-cell maturation patterns.
  • To identify distinct B-cell maturation profiles associated with specific clinical phenotypes and risks in children with CVID.

Main Methods:

  • Utilized four-color flow cytometry to analyze peripheral B-cell subset distribution in 49 children diagnosed with early-onset CVID.
  • Extracted and analyzed comprehensive clinical data from patient medical records.

Main Results:

  • Identified six distinct aberrant peripheral B-cell maturation profiles linked to varying clinical features.
  • An early B-cell maturation block correlated with increased need for replacement therapy and higher risks of enteropathy, granuloma, cytopenia, and lymphoproliferation.
  • Inhibition at the effector stage predicted autoimmune issues (excluding cytopenia), while a naive B-cell stage block was more prevalent in males.

Conclusions:

  • Peripheral B-cell maturation analysis should be a routine diagnostic tool for suspected early-onset CVID in children.
  • This analysis can serve as a surrogate marker to identify pediatric patients at higher risk for specific CVID-related complications.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview